Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Adams & Adams discusses the mandatory recordation process of IP rights in Kenya

Sponsored by

Podcast holder - Adams 2.png

Godfrey Budeli of Adams & Adams explains the key points to consider as Kenya’s Anti-Counterfeit Authority imposes more stringent measures, in the second of a three-part podcast series

In the second episode of a three-part podcast series by Adams & Adams on doing business within the dynamic intellectual property world of Africa, the firm’s anti-counterfeiting head, Godfrey Budeli, talks to Managing IP about new rules for IP rights owners operating in Kenya that are designed to combat counterfeit goods.

As the country seeks to promote and facilitate legitimate trade, Kenya’s Anti-Counterfeit Authority (ACA) has amended the Anti-Counterfeit Act to include a mandatory recordation process of IP rights. Among other changes, the new legislation states that a record of IP rights that pertain to products being imported into Kenya must be provided to the ACA, irrespective of the place of registration. The new legislation will take effect on January 1 2023.

Budeli recently met with Dr Robi Mbugua Njoroge, the CEO of the ACA, to learn more. In a chat with Managing IP’s Rani Mehta, Budeli discusses the legal basis and purpose for the recordal, and the wider impact of the amendments to the Anti-Counterfeit Act, and provides practical examples of how global businesses can react to the changes in Kenya.

Season 2, Episode 1: Oppositions based on well-known rights in Africa

About Adams & Adams

Adams & Adams is an internationally recognised and leading African law firm that specialises in providing intellectual property, corporate and commercial services.

The firm is firmly rooted in Africa – with a tenacious belief in the economic growth potential and spirit of the continent. The head office in Pretoria, the administrative capital of South Africa, provides the perfect gateway through which it partners, supported by some 700 professionals and staff, render a broad range of legal services to clients in Africa and the rest of the world.

Through its associate offices and long-established networks, the firm serves a global client base throughout the African continent in matters of intellectual property, commercial law, property and litigation.

In 2021, experts from Adams & Adams co-produced a popular three-part podcast series on the IP enforcement of pharma in Africa.

You can find all the Managing IP podcasts here.

more from across site and ros bottom lb

More from across our site

IP counsel urge the government to restrict safe harbour exceptions available to intermediaries and clear up doubts with the existing law
A New York lawyer could face sanctions after citing fake judgments generated by ChatGPT, but that doesn’t mean practitioners should shy away from AI
Klaus Grabinski told delegates at a UPC inauguration event that the proposed SEP regulation would limit access to justice
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar shares her thoughts on this year’s annual meeting in Singapore, where debates ranged from AI opportunities to improving law firm culture
The court’s ruling is a good reminder that US parties aren’t guaranteed attorney fees just because they win, say sources
With business confidence in a shaky state, Rachel Tan and Lisa Yong of Rouse discuss how in-house IP teams can manage their trademark portfolios through uncertain times
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
The US Supreme Court’s ruling wasn’t a surprise and reflects a trend that had already been bubbling away for a while, say tech and pharma counsel